HYPOGLYCAEMIC EFFECT AND INTERACTIONS OF ANGIOTENSIN II TYPE I RECEPTOR BLOCKER (TELMISARTAN) WITH ORAL HYPOGLYCAEMIC AGENTS IN STREPTOZOCIN- INDUCED DIABETIC RATS

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Textbook of diabetes

  2017cited by this paper
• Crosstalk between insulin and angiotensin II signalling systems.

  2009cited by this paper
• Olmesartan medoxomil, an angiotensin II receptor blocker ameliorates insulin resistance and decreases triglyceride production in fructose-fed rats.

  2004cited by this paper
• Identification of Telmisartan as a Unique Angiotensin II: Receptor Antagonist With Selective PPARγ–Modulating Activity

  2004cited by this paper
• Mortality and causes of death in the WHO multinational study of vascular disease in diabetes

  2001cited by this paper
• Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

  2000cited by this paper
• Use of Enalapril To Attenuate Decline in Renal Function in Normotensive, Normoalbuminuric Patients with Type 2 Diabetes Mellitus

  1998cited by this paper
• Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk.

  1997cited by this paper
• 1 The definition and classification of diabetes mellitus

  1982cited by this paper
• [Glucose oxidase method].

  1968cited by this paper
• [Definition and classification of diabetes mellitus].

  1966cited by this paper

• In Vitro Investigation of Binding Interactions between Albumin–Gliclazide Model and Typical Hypotensive Drugs

  2021cites this paper